SOM230 (pasireotide) and temozolomide achieve sustained control of tumour progression and ACTH secretion in pituitary carcinoma with widespread metastases (Q43055924)

From Wikidata
Jump to navigation Jump to search
scientific article published on 21 May 2010
edit
Language Label Description Also known as
English
SOM230 (pasireotide) and temozolomide achieve sustained control of tumour progression and ACTH secretion in pituitary carcinoma with widespread metastases
scientific article published on 21 May 2010

    Statements

    SOM230 (pasireotide) and temozolomide achieve sustained control of tumour progression and ACTH secretion in pituitary carcinoma with widespread metastases (English)
    21 May 2010
    760-763

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit